Log in  First Connection?

VirusArchives

Comparison of different methods for the detection of HLA-B* 57:01 allele in people living with HIV in Eastern Uttar Pradesh, India
Virus
 4 min.

 Published on 04/12/2025 |  Original article (Full-text)  | Rai Tulika Kumari et al. | BMC Infectious Diseases 2025; 25(1): 1668

Abacavir (ABC), a guanosine analogue that inhibits reverse transcriptase, is presently used as a first-line treatment for children living with HIV (CLHIV) with a haemoglobin level below 9 g/dl by the National AIDS Control Organization (NACO) in India and it is also suggested as an alternative initial...

Readability and information quality of LLM-Generated HIV content: a methodological content evaluation
Virus
 7 min.

 Published on 27/11/2025 |  Original article (Full-text)  | Chen Guihua et al. | BMC Infectious Diseases 2025; 25(1): 1624

Since the identification of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) in The 1980s, The epidemic has remained a major public-health challenge. In 2023, an estimated 39.6 million people were living with HIV worldwide, with 1.3 million new infections and...

Characteristics of extracellular vesicle-derived lncRNAs during the progression of HBV-related hepatocellular carcinoma
Virus
 7 min.

 Published on 20/11/2025 |  Original article (Full-text)  | Ma Yanan et al. | BMC Cancer 2025; 25(1): 1766

Liver cancer poses a significant threat to global public health security, presenting substantial challenges in clinical prevention and management. According to the latest World Health Organization statistics, approximately 760,000 deaths annually are attributed to liver cancer worldwide [1]. Hepatocellular...

Global burden of HIV and drug-resistant tuberculosis co-infection and its attributable risk factors, 1990 to 2021, with projections to 2031
Virus
 4 min.

 Published on 13/11/2025 |  Original article (Full-text)  | Feng Liting et al. | BMC Infectious Diseases 2025; 25(1): 1521

Multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) represent a critical antimicrobial resistance threat, significantly compromising treatment efficacy and overwhelming healthcare systems in endemic regions [1, 2]. Compared to drug-susceptible tuberculosis (TB) (more than 85%...